Who
Zhenya Lindgardt
Chief Executive Officer
Company insider
Files Form 4 as: Chief Executive Officer, Sera Prognostics.
In numbers
- Trades disclosed
- 41
- Buys
- 0
- Sells
- 25
- Bought
- $0
- Sold
- $2.3M
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 8 Nov 2021
- Last trade
- 10 Sep 2026
- Last filed
- 11 Sep 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 10 Sep 2026filed 11 Sep 2026 | SERA Sera PrognosticsDiagnostics & Labs | SEC FORM 4 Sold | $14K7,022 at $2.00 | filing |
| 10 Sep 2026filed 11 Sep 2026 | SERA Sera PrognosticsDiagnostics & Labs | SEC FORM 4 Sold | $14K7,022 at $2.00 | filing |
| 8 Sep 2026filed 9 Sep 2026 | SERA Sera PrognosticsDiagnostics & Labs | SEC FORM 4 Sold | $40K20,139 at $2.00 | filing |
| 8 Sep 2026filed 9 Sep 2026 | SERA Sera PrognosticsDiagnostics & Labs | SEC FORM 4 Sold | $40K20,139 at $2.00 | filing |
| 11 Jun 2026filed 15 Jun 2026 | SERA Sera PrognosticsDiagnostics & Labs | SEC FORM 4 Sold | $14K6,990 at $2.01 | filing |
| 11 Jun 2026filed 15 Jun 2026 | SERA Sera PrognosticsDiagnostics & Labs | SEC FORM 4 Sold | $14K6,990 at $2.01 | filing |
| 9 Jun 2026filed 10 Jun 2026 | SERA Sera PrognosticsDiagnostics & Labs | SEC FORM 4 Sold | $43K20,755 at $2.08 | filing |
| 9 Jun 2026filed 10 Jun 2026 | SERA Sera PrognosticsDiagnostics & Labs | SEC FORM 4 Sold | $43K20,755 at $2.08 | filing |
| 12 Mar 2026filed 13 Mar 2026 | SERA Sera PrognosticsDiagnostics & Labs | SEC FORM 4 Code A | —154,440 at $0.00 | filing |
| 12 Mar 2026filed 13 Mar 2026 | SERA Sera Prognosticsoption or derivative · Diagnostics & Labs | SEC FORM 4 Code A | —239,442 at $0.00 | filing |
| 12 Mar 2026filed 13 Mar 2026 | SERA Sera Prognosticsoption or derivative · Diagnostics & Labs | SEC FORM 4 Code A | —239,442 at $0.00 | filing |
| 12 Mar 2026filed 13 Mar 2026 | SERA Sera PrognosticsDiagnostics & Labs | SEC FORM 4 Code A | —154,440 at $0.00 | filing |
| 11 Mar 2026filed 12 Mar 2026 | SERA Sera PrognosticsDiagnostics & Labs | SEC FORM 4 Sold | $6,0652,973 at $2.04 | filing |
| 11 Mar 2026filed 12 Mar 2026 | SERA Sera PrognosticsDiagnostics & Labs | SEC FORM 4 Sold | $6,0652,973 at $2.04 | filing |
| 10 Mar 2026filed 12 Mar 2026 | SERA Sera PrognosticsDiagnostics & Labs | SEC FORM 4 Sold | $43K22,639 at $1.90 | filing |
| 10 Mar 2026filed 12 Mar 2026 | SERA Sera PrognosticsDiagnostics & Labs | SEC FORM 4 Sold | $43K22,639 at $1.90 | filing |
| 10 Dec 2025filed 11 Dec 2025 | SERA Sera PrognosticsDiagnostics & Labs | SEC FORM 4 Sold | $14K4,155 at $3.31 | filing |
| 9 Dec 2025filed 10 Dec 2025 | SERA Sera PrognosticsDiagnostics & Labs | SEC FORM 4 Sold | $86K28,215 at $3.04 | filing |
| 10 Nov 2025filed 12 Nov 2025 | SERA Sera PrognosticsDiagnostics & Labs | SEC FORM 4 Sold | $30K11,594 at $2.62 | filing |
| 11 Sep 2025filed 12 Sep 2025 | SERA Sera PrognosticsDiagnostics & Labs | SEC FORM 4 Sold | $10K3,246 at $3.13 | filing |
News
Reviewing Black Diamond Therapeutics (NASDAQ:BDTX) & Sera Prognostics (NASDAQ:SERA)SERA · tickerreport.com · 22 Oct 2026Head to Head Survey: Immunocore (NASDAQ:IMCR) and Sera Prognostics (NASDAQ:SERA)SERA · dailypolitical.com · 20 Oct 2026Arrowhead Pharmaceuticals (NASDAQ:ARWR) versus Sera Prognostics (NASDAQ:SERA) Head to Head ReviewSERA · themarketsdaily.com · 18 Oct 2026
0 headlines in the last 90 days name Zhenya Lindgardt; 3 articles from the last 14 days about the 1 company they traded most, at most three about any one of them.